Page last updated: 2024-08-21

ethambutol and cerulenin

ethambutol has been researched along with cerulenin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansal, NP; Dick, JD; Houston, TA; Jones, PB; Parrish, NM; Stapon, A; Townsend, CA1
Chung, WJ; Jacobs, WR; Ngo, SC; Sayahi, H; Welch, JT; Zimhony, O1
Jacobs, WR; Sayahi, H; Shekhtman, A; Welch, JT; Zimhony, O1
Bera, S; Mondal, D1
Barrow, WW; Goh, KS; Horgen, L; Rastogi, N1

Reviews

1 review(s) available for ethambutol and cerulenin

ArticleYear
Insights of synthetic analogues of anti-leprosy agents.
    Bioorganic & medicinal chemistry, 2019, 07-01, Volume: 27, Issue:13

    Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship

2019

Other Studies

4 other study(ies) available for ethambutol and cerulenin

ArticleYear
A new class of antituberculosis agents.
    Journal of medicinal chemistry, 2000, Aug-24, Volume: 43, Issue:17

    Topics: Amides; Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Sulfones

2000
Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacterial Proteins; Cell-Free System; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Kinetics; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; NADP; Oxidation-Reduction; Pyrazinamide; Reproducibility of Results; Substrate Specificity

2007
Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I.
    Bioorganic & medicinal chemistry letters, 2011, Aug-15, Volume: 21, Issue:16

    Topics: Bacterial Proteins; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Enzyme Inhibitors; Fatty Acid Synthases; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; NADP; Pyrazinamide; Stereoisomerism; Structure-Activity Relationship

2011
Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.
    FEMS immunology and medical microbiology, 1998, Volume: 21, Issue:2

    Topics: Antibiotics, Antitubercular; Antitubercular Agents; Cerulenin; Cinnamates; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

1998